Stocktoria
Tyra Biosciences, Inc. TYRA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-09-15
Tyra Biosciences, Inc. statistics & valuation
Market cap$1.9B
P / B7.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -42.4% | -23.8% | -30.6% | -20.8% | -8.6% |
| Return on equity | -46.3% | -25.2% | -33.8% | -21.5% | -8.7% |
| Current ratio | 14.67 | 23.81 | 13.80 | 45.13 | 84.09 |
Source: SEC EDGAR filings · CIK 0001863127 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.